港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

藥捷安康-B

68.550

-1.050-1.51%

成交量：23.85萬

成交額：1,651.18萬

市值：273.51億

市盈率：-78.63

高：70.200

開：69.600

低：68.300

收：69.600

52周最高：679.500

52周最低：20.200

股本：3.99億

香港流通股本：3.04億

量比：0.43

換手率：0.08%

股息：- -

股息率：- -

每股收益(LYR):-0.872

淨資產收益率：-62.88%

總資產收益率：-32.06%

市淨率：57.27

市盈率(LYR):-78.63

市銷率: - -

資料載入中...

總覽公司新聞資訊公告

藥捷安康-B11月05日主力淨流入4018.6萬元散户資金拋售

港股藥捷安康-B漲幅擴大至20%

南方财经网

部分港股醫藥股反彈藥捷安康漲近5%

每日经济新闻

創新藥資本調整三個月，誰在改變？

CNS專題1：抗抑鬱新靶點國內有哪些映射？

石藥集團執行董事被罰500萬元，海思科1類新藥獲批臨床，藥捷安康拿下8.8億美元BD合作，百奧泰3.3億元成立生物藥業公司

藥捷安康宣佈達成重磅授權合作！東陽光藥新藥IND……

医药经济报

一款臨床前國產新藥超8億美元出海，有何潛力？

藥捷安康-B11月03日獲主力加倉419.0萬元

藥捷安康-B(02617)與Neurocrine達成項目合作

藥捷安康-B與Neurocrine Biosciences Inc達成Nlrp3抑制劑合作

藥捷安康-B10月31日主力淨流入719.0萬元散户資金拋售

藥捷安康-B10月24日主力淨流入207.0萬元散户資金拋售

港股異動 | 生物技術股走弱，榮昌生物跌近12%

老虎资讯综合

港股醫藥板塊再現異動拉升，多隻個股走出亮眼行情！

港股異動 | 藥捷安康-B(02617)一度升逾25% 於2025年ESMO年會上公布替恩戈替尼研究數據並獲口頭報告

港股速報 | 後勁不足港股衝高回落如何「禦寒」

每日经济新闻

藥捷安康-B(02617.HK)盤中跌超11%

每日经济新闻

生育津貼加速發放至個人；全球首套腦機交互定製化磁共振平台啓用

21世纪经济报道

藥捷安康-B(02617)擬實行H股全流通

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02617/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"藥捷安康-B","latestPrice":68.55,"timestamp":1776402173672,"preClose":69.6,"halted":0,"volume":238500,"delay":0,"changeRate":-0.015086206896551685,"floatShares":304000000,"shares":399000000,"eps":-0.8717946309040091,"marketStatus":"交易中","change":-1.05,"latestTime":"04-17 13:04:29","open":69.6,"high":70.2,"low":68.3,"amount":16511800,"amplitude":0.027299,"askPrice":68.85,"askSize":3500,"bidPrice":68.5,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.8717946309040091,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1776413400000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":69.6,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.431964,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":304000000,"roa":"-32.06%","roe":"-62.88%","lyrEps":-0.871795,"volumeRatio":0.431964,"shares":399000000,"dividePrice":0,"high":70.2,"amplitude":0.027299,"preClose":69.6,"low":68.3,"week52Low":20.2,"pbRate":"57.27","week52High":679.5,"institutionHeld":0,"latestPrice":68.55,"committee":-0.555556,"eps":-0.8717946309040091,"divideRate":0,"volume":238500,"delay":0,"ttmEps":-0.8717946309040091,"open":69.6,"prevYearClose":114.9,"prevWeekClose":68.6,"prevMonthClose":66.5,"prevQuarterClose":66.5,"fiveDayClose":68.6,"twentyDayClose":72,"sixtyDayClose":95.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-31","symbol":"02617","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2026-04-15","current":-79.81754,"percent":0.7,"low":-380.446233,"twenty":-254.928912,"median":-113.347254,"eighty":-57.896187,"high":-17.403134,"avg":-149.738338,"sd":94.755164,"marketCap":28049533599},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658},{"date":"2025-11-21","current":-312.892206,"twenty":-281.392507,"median":-71.392356,"eighty":-43.133487,"marketCap":81205255711},{"date":"2025-11-28","current":-305.66478,"twenty":-292.6573,"median":-72.756691,"eighty":-44.126885,"marketCap":79617665179},{"date":"2025-12-05","current":-292.058382,"twenty":-294.387608,"median":-99.507708,"eighty":-45.187328,"marketCap":76204345536},{"date":"2025-12-12","current":-243.995471,"twenty":-293.167092,"median":-152.573856,"eighty":-47.193393,"marketCap":63781449623},{"date":"2025-12-19","current":-248.269013,"twenty":-292.997062,"median":-174.177612,"eighty":-49.176233,"marketCap":65051522048},{"date":"2025-12-24","current":-196.609225,"twenty":-292.87226,"median":-176.029803,"eighty":-49.50215,"marketCap":51676071816},{"date":"2026-01-02","current":-170.268162,"twenty":-292.367293,"median":-176.029803,"eighty":-50.024601,"marketCap":44928812055},{"date":"2026-01-09","current":-172.395935,"twenty":-291.502465,"median":-173.687618,"eighty":-50.606284,"marketCap":45603538031},{"date":"2026-01-16","current":-142.824051,"twenty":-290.689477,"median":-172.622298,"eighty":-50.90198,"marketCap":37903723951},{"date":"2026-01-23","current":-125.658859,"twenty":-289.035292,"median":-170.268162,"eighty":-51.777834,"marketCap":33316302355},{"date":"2026-01-30","current":-123.813683,"twenty":-286.862177,"median":-169.566856,"eighty":-52.840115,"marketCap":32977154367},{"date":"2026-02-06","current":-105.494623,"twenty":-283.350344,"median":-167.82666,"eighty":-53.700055,"marketCap":28169232889},{"date":"2026-02-13","current":-102.143547,"twenty":-281.033113,"median":-142.637109,"eighty":-54.549461,"marketCap":27431087268},{"date":"2026-02-20","current":-99.091969,"twenty":-280.673719,"median":-140.820404,"eighty":-54.88737,"marketCap":26573242357},{"date":"2026-02-27","current":-101.401985,"twenty":-277.873293,"median":-135.446139,"eighty":-55.077905,"marketCap":27490936913},{"date":"2026-03-06","current":-136.499284,"twenty":-268.489172,"median":-127.818396,"eighty":-56.170035,"marketCap":36707782236},{"date":"2026-03-13","current":-113.20329,"twenty":-265.946326,"median":-125.658859,"eighty":-56.966285,"marketCap":30583168569},{"date":"2026-03-20","current":-101.699451,"twenty":-264.885138,"median":-122.419285,"eighty":-57.460964,"marketCap":27371237623},{"date":"2026-03-27","current":-103.891016,"twenty":-259.5894,"median":-118.720319,"eighty":-57.713018,"marketCap":27889934546},{"date":"2026-04-02","current":-103.689961,"twenty":-256.279611,"median":-116.735022,"eighty":-57.836913,"marketCap":27969734073},{"date":"2026-04-10","current":-80.663784,"twenty":-255.242863,"median":-113.754326,"eighty":-57.879207,"marketCap":27371237623},{"date":"2026-04-15","current":-82.483241,"twenty":-254.928912,"median":-113.347254,"eighty":-57.896187,"marketCap":28049533599}],"updateTime":1776378729075},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581246817","title":"藥捷安康-B11月05日主力淨流入4018.6萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2581246817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581246817?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 16:15","pubTimestamp":1762330545,"startTime":"0","endTime":"0","summary":"11月05日, 药捷安康-B股价涨26.30%，报收228.60元，成交金额9.6亿元，换手率1.58%，振幅27.96%，量比2.72。药捷安康-B今日主力资金净流入4018.6万元，上一交易日主力净流出181.7万元。该股近5个交易日上涨24.58%，主力资金累计净流入4974.8万元；近20日主力资金累计净流入6407.5万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516200894f0788e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516200894f0788e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581749954","title":"港股藥捷安康-B漲幅擴大至20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581749954","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581749954?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 16:12","pubTimestamp":1762330336,"startTime":"0","endTime":"0","summary":"港股药捷安康-B涨幅扩大至20%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053555881526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581790003","title":"部分港股醫藥股反彈 藥捷安康漲近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790003","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581790003?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 09:59","pubTimestamp":1762307949,"startTime":"0","endTime":"0","summary":"每经AI快讯，11月5日，截至发稿，药捷安康-B(02617.HK)涨4.97%、北海康成-B(01228.HK)涨2.70%、中国抗体-B(03681.HK)涨2.48%、康诺亚-B(02162.HK)涨2.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053555629975.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053555629975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581764942","title":"創新藥資本調整三個月，誰在改變？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581764942","media":"研发客","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581764942?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 05:00","pubTimestamp":1762290042,"startTime":"0","endTime":"0","summary":"研发客根据Choice数据统计整理可见，56家生物医药公司中，21家公司在过去三个月实现上涨，其余35家公司均出现不同程度下跌。其中，药捷安康的势头最猛，过去三个月的区间涨幅达384.32%。公司预计NDA将于今年三季度获批，不过显然尚未兑现。信达生物则在最新的公告中披露，2025年第三季度，公司产品收入为超33亿元人民币，同比增长40%。震荡调整之下管线推进速度如何过去三个月，创新药板块跌幅最大的是中国抗体，下跌49.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105050335a6e143cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105050335a6e143cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828557.USD","LU2097828805.USD","LU2097828631.EUR","LU1969619763.USD","LU2242644610.SGD","BK1161","01801","09926","BK1583","LU0455707207.USD","LU2328871848.SGD","LU2488822045.USD","LU2097828474.EUR","02142","06978","BK1574","BK1589","02617","LU2097828714.EUR","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581590745","title":"CNS專題1：抗抑鬱新靶點 國內有哪些映射？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581590745","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581590745?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 00:00","pubTimestamp":1762272000,"startTime":"0","endTime":"0","summary":"创新药CNS系列专题：抗抑郁市场潜力巨大，众多新靶点即将迎来催化：抑郁市场空间庞大：根据2021年全球疾病负担研究，全球抑郁症发病数超3.5亿人，其中国内抑郁症患者超过9000万人，患者疾病负担巨大。新一代抗抑郁药的研发需在“快速起效”与“长期安全”间寻求平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110515274694f05d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110515274694f05d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0540923850.HKD","01167","LU0634319403.HKD","BK1574","09926","LU0348766576.USD","LU2476274308.USD","LU0348767384.USD","LU0417516738.SGD","LU1794554557.SGD","LU2476274720.SGD","LU0417516902.SGD","09887","LU0348784397.USD","02696","LU0348783233.USD","LU2778985437.USD","LU1720050803.USD","LU2488822045.USD","IE00BPRC5H50.USD","02617","IE00B543WZ88.USD","LU0561508036.HKD","IE00B5MMRT66.SGD","LU0348827113.USD","01801","LU0417516571.SGD","LU0348735423.USD","LU2399975544.HKD","BK1161","LU0348825331.USD","LU1961090484.USD","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580246423","title":"石藥集團執行董事被罰500萬元，海思科1類新藥獲批臨床，藥捷安康拿下8.8億美元BD合作，百奧泰3.3億元成立生物藥業公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2580246423","media":"谈医说药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580246423?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 22:40","pubTimestamp":1762180839,"startTime":"0","endTime":"0","summary":"截至目前，瑞维鲁胺片相关项目累计研发投入约6.93亿元。证监会经调查认为，潘卫东在新诺威拟与石药百克进行重组交易公开前，知悉内幕信息，利用石药集团全资附属公司恩必普的证券账户，买入新诺威274.258万股，买入金额为9998.88万元，构成内幕交易。证监会责令潘卫东依法处理非法持有的证券，并处罚款500万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104010706a6de5f98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104010706a6de5f98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU0067412154.USD","BK1191","LU1226287875.USD","02005","IE00BZ08YR35.GBP","LU1152091168.USD","LU1226287792.SGD","LU1152091754.HKD","IE0008369823.USD","IE0008368742.USD","LU1226287529.USD","LU0326950275.SGD","LU0314109678.HKD","BK1521","LU0315179316.USD","LU0880133367.SGD","IE00B031HY20.USD","01093","LU1226288170.HKD","LU1813983027.USD","LU1008478684.HKD","LU1951186391.HKD","LU0072913022.USD","LU2460026573.USD","LU1328277881.USD","02617","IE00B543WZ88.USD","BK1161","LU0140636845.USD","LU1993786604.SGD","LU1226288253.USD","BK1515","LU0501845795.SGD","LU2039709279.SGD","LU1807302812.USD","LU1960683339.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580478370","title":"藥捷安康宣佈達成重磅授權合作！東陽光藥新藥IND……","url":"https://stock-news.laohu8.com/highlight/detail?id=2580478370","media":"医药经济报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580478370?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 19:59","pubTimestamp":1762171149,"startTime":"0","endTime":"0","summary":"药捷安康宣布达成一项超8亿美元授权合作11月3日，药捷安康（南京）科技股份有限公司发布公告宣布，公司与Neurocrine Biosciences, Inc.订立一项付特许权使用费的专利转让及研究合作协议，以开发NLRP3抑制剂，用于治疗多种疾病。东阳光药抗乙肝siRNA新药获批临床11月1日，国家药品监督管理局药品审评中心官网最新公开显示，东阳光药申报的1类新药HECN30227获批临床，拟定适应症为慢性乙型肝炎。根据东阳光药公开资料，这是其自主研发的siRNA疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103230902a4857549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103230902a4857549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887","02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2580247388","title":"一款臨床前國產新藥超8億美元出海， 有何潛力？","url":"https://stock-news.laohu8.com/highlight/detail?id=2580247388","media":"医药时间","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580247388?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 17:14","pubTimestamp":1762161272,"startTime":"0","endTime":"0","summary":"11 月 3 日，药捷安康宣布与 Neurocrine Biosciences 签署一项专利转让及研究合作协议。值得注意的是，大量的临床前及临床研究已表明，NLRP3 炎性小体是肥胖症的关键治疗靶点。作为一种新型、高效、选择性的 NLRP3 抑制剂，TT-02332 可有效抑制过度炎症，并具有良好的剂量依赖性。体外试验结果表明，TT-02332 对人巨噬细胞系 THP-1 及人全血中的 NLRP3 炎症小体具有强效抑制作用，突显了其潜在的临床疗效。此外，TT-02332 表现出较高的选择性，对 NLRP3 的选择性较其他炎症小体超过 1000 倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103213611a6de0b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103213611a6de0b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580224736","title":"藥捷安康-B11月03日獲主力加倉419.0萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580224736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580224736?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 16:15","pubTimestamp":1762157723,"startTime":"0","endTime":"0","summary":"11月03日, 药捷安康-B股价涨2.99%，报收189.30元，成交金额3.3亿元，换手率0.57%，振幅6.53%，量比0.74。药捷安康-B今日主力资金净流入419.0万元，上一交易日主力净流入719.0万元。该股近5个交易日下跌0.89%，主力资金累计净流入1138.0万元；近20日主力资金累计净流入2570.6万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103161701a6dd5e2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103161701a6dd5e2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580230834","title":"藥捷安康-B(02617)與Neurocrine達成項目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2580230834","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580230834?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 08:17","pubTimestamp":1762129069,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 发布公告，Neurocrine Biosciences, Inc.与本公司订立一项付特许权使用费的专利转让及研究合作协议，以开发NLRP3抑制剂，用于治疗多种疾病(该协议)。根据该协议，公司将有权获得预付款，并且根据Neurocrine的开发和商业化进展，公司可能会收到与研发里程碑和销售里程碑相关的进一步里程碑付款，该协议的总潜在价值为 8.815亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617)与Neurocrine达成项目合作","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108119128","title":"藥捷安康-B與Neurocrine Biosciences Inc達成Nlrp3抑制劑合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1108119128","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108119128?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 08:06","pubTimestamp":1762128409,"startTime":"0","endTime":"0","summary":"药捷安康-B与Neurocrine Biosciences Inc达成Nlrp3抑制剂合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580453324","title":"藥捷安康-B10月31日主力淨流入719.0萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2580453324","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580453324?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898534,"startTime":"0","endTime":"0","summary":"10月31日, 药捷安康-B股价涨5.88%，报收183.80元，成交金额7.0亿元，换手率1.25%，振幅15.84%，量比1.73。药捷安康-B今日主力资金净流入719.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.13%，主力资金累计净流入925.9万元；近20日主力资金累计净流入2151.7万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161916974beb07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161916974beb07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577518085","title":"藥捷安康-B10月24日主力淨流入207.0萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2577518085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577518085?lang=zh_tw&edition=fundamental","pubTime":"2025-10-24 16:15","pubTimestamp":1761293722,"startTime":"0","endTime":"0","summary":"10月24日, 药捷安康-B股价涨1.70%，报收191.00元，成交金额7.6亿元，换手率1.31%，振幅13.68%，量比0.63。药捷安康-B今日主力资金净流入207.0万元，上一交易日主力净流出928.1万元。该股近5个交易日下跌5.42%，主力资金累计净流入1101.7万元；近20日主力资金累计净流入769.1万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102416164094db34b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102416164094db34b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152404472","title":"港股異動 | 生物技術股走弱，榮昌生物跌近12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152404472","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152404472?lang=zh_tw&edition=fundamental","pubTime":"2025-10-23 13:25","pubTimestamp":1761197137,"startTime":"0","endTime":"0","summary":"10月23日，港股$生物(000504)$技术股盘中走弱，$荣昌生物(09995)$跌近12%，$药捷安康-B(02617)$跌超8%，$科伦博泰生物-B(06990)$跌超6%，$晶泰控股(02228)$、$映恩生物-B(09606)$跌近6%，$药明生物(02269)$、$康方生物(09926)$、$百济神州(06160)$跟跌。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"df43def6c60d84e15ce9d1605944911d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","09926","09995","06160","02228","02269","ONC","02617","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577335143","title":"港股醫藥板塊再現異動拉升，多隻個股走出亮眼行情！","url":"https://stock-news.laohu8.com/highlight/detail?id=2577335143","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577335143?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 11:25","pubTimestamp":1761103512,"startTime":"0","endTime":"0","summary":"10月22日，港股医药板块再现异动拉升，多只个股走出亮眼行情。政策层面的积极导向也为港股医药股的走强提供了重要保障。从市场节奏来看，当前港股医药股的上涨具备坚实的催化剂支撑。对于市场而言，港股医药股的强势行情不仅是短期资金推动的结果，更反映出产业长期发展逻辑的重构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102211310194d6f0ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102211310194d6f0ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","09926","01276","02898","06978","BK1161","BK1574","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577387025","title":"港股異動 | 藥捷安康-B(02617)一度升逾25% 於2025年ESMO年會上公布替恩戈替尼研究數據並獲口頭報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387025","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577387025?lang=zh_tw&edition=fundamental","pubTime":"2025-10-22 09:53","pubTimestamp":1761098036,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药捷安康-B一度涨超25%，截至发稿，涨15.81%，报200港元，成交额7.12亿港元。消息面上，据药捷安康官微消息，10月20日，药捷安康宣布，公司在2025年欧洲肿瘤内科学会年会上公开了核心产品替恩戈替尼于胆管癌适应症的最新汇总研究数据。据悉，替恩戈替尼是一款自主研发、注册性临床阶段的创新多靶点小分子激酶抑制剂，通过靶向肿瘤细胞和改善肿瘤微环境发挥抗肿瘤作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 药捷安康-B(02617)一度涨超25% 于2025年ESMO年会上公布替恩戈替尼研究数据并获口头报告","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577280698","title":"港股速報 | 後勁不足 港股衝高回落 如何「禦寒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2577280698","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577280698?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 17:14","pubTimestamp":1761038056,"startTime":"0","endTime":"0","summary":"今日（10月21日），港股市场一度高开高走，但下午明显后劲不足，最终各类指数冲高回落。截至收盘，恒指报收于26027.55点，上涨168.72点，涨幅0.65%。恒生科技指数报收于6007.94点，上涨74.77点，涨幅1.26%。市场方面，随着近期气候逐渐进入冬季，如何御寒备受关注，而“温暖”赛道开始成为热点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510213540011819.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213540011819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1178","BK1225","BK1227","BK1505","BK1538","02617","LU0287142896.SGD","BK1161","BK1594","LU0173614495.USD","06885","03998","01088","BK1502","BK1500","LU1808992512.USD","BK1512","LU1675838814.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577684439","title":"藥捷安康-B(02617.HK)盤中跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577684439","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577684439?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 15:38","pubTimestamp":1761032330,"startTime":"0","endTime":"0","summary":"每经AI快讯，药捷安康-B(02617.HK)盘中跌超11%，截至发稿，跌9.74%，报176.2港元，成交额5.91亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510213539907874.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213539907874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577489082","title":"生育津貼加速發放至個人；全球首套腦機交互定製化磁共振平台啓用","url":"https://stock-news.laohu8.com/highlight/detail?id=2577489082","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577489082?lang=zh_tw&edition=fundamental","pubTime":"2025-10-21 07:59","pubTimestamp":1761004742,"startTime":"0","endTime":"0","summary":"政策动向国家医保局：预计到11月1日25省份、近九成统筹区实现生育津贴直接发放至个人10月20日，据国家医保局消息，自9月以来，江西、安徽、陕西等省陆续在全省推开生育津贴直接发放至个人。辽宁、江苏已于近日正式发文，将于11月1日起在全省实现生育津贴直达个人。预计到11月1日，全国将有25个省份（含新疆生产建设兵团）实现生育津贴直接发放至个人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510213539281163.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510213539281163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","09996","BK1574","BK1100","09997","BK1583","02617","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2576483767","title":"藥捷安康-B(02617)擬實行H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2576483767","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576483767?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 17:49","pubTimestamp":1760953755,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，于2025年10月20日，公司董事会已考虑及批准向中国证监会提交申请，将公司10名股东持有的4497.11万股公司内资股转换为公司H股，占公司于本公告日期已发行股份总数约11.33%。于取得所有相关批准(包括中国证监会及联交所的批准)并遵守所有适用法律、法规及规则后，该等内资股将转换为H股，并符合资格于联交所主板上市及买卖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617)拟实行H股全流通","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":106,"code":"91000000","status":"200"}]}}